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Abstract
Since ancient times, plants have always been a reliable and important source of bioactive 
compounds used to treat several diseases, and thus play a central role in human health. 
In addition, medicinal plants are a rich source of bioactive secondary metabolites that 
have a wide range of medicinal uses. This is the reason why, currently, 90% of drugs 
come from natural or semisynthetic origins. Chemical diversity of plants made them 
one of the main sources for the extraction and purification of secondary metabolites. On 
the other hand, pain has always been a cause of concern to humans who searched for a 
remedy from natural sources, mostly from plants. In this respect, substances that relieve 
pain (algesia) can be described as analgesics (painkillers). Chemically diverse structures 
have been identified as pain relievers; they relieve pain through various mechanisms and 
act either centrally (opioids receptor agonism) or peripherally. Therefore, this chapter is 
intended to summarize the literature pertaining to plants and their constituents discov‐
ered with analgesic potential in the last four decades.
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1. Introduction
Medicinal plants are a rich source for making phytochemicals with great efficiency and selec‐
tivity. Since the middle of the nineteenth century, many natural products were obtained in a 
pure form from plants; most of these products are available to be used as active agents in mod‐
ern medication. Despite the significant advances in synthetic drugs, side effects remain that 
necessitate the search for effective, inexpensive, and more accessible drugs. Medicinal plants 
may provide such valuable therapeutic alternatives. Use of traditional medicinal plants with 
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analgesic effects has recently gained popularity worldwide because of their natural origin 
and fewer side effects [1]. Moreover, medicinal plant extracts and their fractions are used by 
80% of the world population for their simple health care necessities. They are the significant 
source of natural drug molecules and secondary metabolites which can be used in modern 
medicine for the cure of various diseases. Throughout history, people relied on an old‐style 
traditional system of medicine to cure diseases and disorders, which with time has gained 
popularity and global significance. Present approximations suggest that in numerous devel‐
oping countries, a large proportion of the population seriously trusts traditional specialists 
and local healers in addition to trusting medicinal plants and medicinal plants‐derived drugs 
to cure diseases, though modern drugs may be accessible in these countries. However, herbal 
medicines must be approved by local authorities before being prescribed.
Native people and early civilizations tested different plants and animal parts to determine 
what effect they have. Using trial and error methods, local healers and shamans found that 
particular plants or parts had therapeutic activity. These indicated the first crude drugs and 
this knowledge was passed down through the generations and arranged similar to the old‐
style Chinese medicine as well as Ayurveda [2, 3]. Many traditional medicines have actual 
and useful effects, and extracts of these medicines have led to the discovery of bioactive mol‐
ecules and to the growth of current chemically active pure drug discovery [3].
Recently, several people in developed countries have turned to complementary treatments 
including the use of therapeutic herbs [2]. In this context, the term Ayurvedic medicine has 
been introduced which is mainly in the form of a crude extract that consists of a mixture of 
several compounds; however, when the active agents are isolated and purified, they individu‐
ally fail to give the desired activity. Therefore, pharmacological data on several medicinal 
plants and isolated compounds are required to regulate active compounds with the desired 
biological potency. Furthermore, modern methods of production, purification, and standard‐
ization should be followed to obtain plant‐derived materials of high quality [3]. In ancient 
times, humans extracted chemicals from plants for treatment of various diseases, and kept 
records of useful properties and uses of medical plants, such as willow bark and Papaver som‐
niferum, used as a pain killers. It is now documented that willow bark contains acetylsalicylic 
acid, the active ingredient in aspirin [3].
Due to its frequent occurrence, pain is a public health problem with considerable socioeco‐
nomic effects. It is an indication of several illnesses and it is predicted that about 80–100% of 
the population will experience, for example, back pain once in life [4]. Pain treatment requires 
analgesics including, anti‐inflammatory medicines, which at maximum doses have analgesic 
properties. In this respect, inhibition of nitric oxide (NO) and prostaglandin E2 production 
has been reported as a potential therapy for different inflammatory disorders [5]. Though 
several anti‐inflammatory and analgesics drugs exist on the shelves, current drug therapy is 
related to certain adverse effects such as gastrointestinal irritation [6], bronchospasm, fluid 
retention, and extension of bleeding time. Consequently, it is necessary to discover new drugs 
with fewer adverse effects. Accordingly, people resort to medicinal plants for discovery and 
development of new drugs [7]. In addition, scientists discovered that extracts from medicinal 
plants can be a significant source of natural and safer new drugs for the treatment of inflam‐
mation and pain [8, 9].
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2. Analgesic (painkiller)
Analgesics drugs include paracetamol (acetaminophenol), in addition to the nonsteroidal anti‐
inflammatory drugs (NSAIDs) such as salicylates, and morphine and oxycodone isolated from 
opium. There are many classes of drugs available for treatment of pain. Each class has a dis‐
similar history of uses for treatment of different types of pain and in different types of people.
Analgesic selection is governed by the type of pain. For example, for neuropathic pain, tra‐
ditional analgesics are less effective, whereas drugs that are not normally mentioned as anal‐
gesics, such as tricyclic antidepressants and anticonvulsants medicine, are more effective as 
pain killers [10]. In general, pain killers are not used if there have other serious side effects. 
For pain relief, drugs are classified based on either their chemical structures or on their uses 
for different classes of medical illnesses. Moreover, some drugs are arranged according to the 
requirements of people who use them. In other cases, these drugs are listed based on acces‐
sibility in a geographical zone, possibly to stop obtaining drugs which are prohibited there.
2.1. Acetaminophen
Acetaminophen (paracetamol) is a common medication to treat fever and pain [11]; this 
medicine is mostly used for slight and moderate body pain. On the other hand, paracetamol 
in combination with opioid are used for severe pain, such as pain after surgery [12]. 
Acetaminophen is used orally or taken intravenously [12] and its effect lasts between 2 and 
4 hours. Acetaminophen is classified as slight analgesic [13] and is harmless at the recom‐
mended doses [13, 14].
2.2. NSAIDs as analgesics drug
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are a class of medications that provide anti‐
pyretic and analgesic effects, and in higher doses have anti‐inflammatory potential. They 
are among the most commonly used analgesics for arthritic pain worldwide. The prominent 
members of this group of drugs are ibuprofen, aspirin, and naproxen, which are available and 
used in most countries [15]. Analgesic NSAIDs are nonnarcotic and are used as a nonaddic‐
tive alternate to narcotics.
2.3. Archetypal opioids
The archetypal opioids (morphine) and all similar extracts, as well as other opioids, affect 
the cerebral opioid receptor coordination [16, 17]. Tramadol is a serotonin‐norepineph‐
rine reuptake inhibitor (SNRI) through feeble μ‐opioid receptor agonist actions, whereas 
buprenorphine is a partial agonist of the μ‐opioid receptor [18]. Tramadol and venlafaxine 
are structurally very close to codeine that exerts analgesia not by individual opioid‐like prop‐
erties but through less agonism of the μ‐opioid receptor and by acting as a serotonin‐releasing 
agent and a norepinephrine reuptake inhibitor [19–22]. Opioids, though very active analge‐
sics, might have certain unfriendly side effects. Those patients starting morphine might expe‐
rience vomiting and nausea [23].
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2.4. Alcohol compounds as analgesics
Alcohol compounds are also documented to treat pain [24]; however, alcohols have biologi‐
cal, mental, and social properties that affect the significance of their use for treatment of pain 
[25]. Although reasonable usage of alcohol can reduce certain kinds of pain under certain 
conditions [26], the use of alcohol to cure pain, however, is encountered by the negative effects 
of extreme drinking [27].
2.5. Cannabis and cannabinoids as analgesic
Cannabis or medical marijuana is related to the use of cannabis and isolated cannabinoids to 
cure diseases and relieve pain [28]. In addition, cannabis and its compounds are used to treat 
chronic pain. The best‐known analgesic of these cannabinoids for treatment of pain is tetrahy‐
drocannabinol, or the best known as THC [29–31].
In comparison, numerous mixtures of analgesic drugs have been determined to have insuf‐
ficient effectiveness compared to similar doses of their separate mechanisms. Furthermore, 
these analgesic mixtures frequently result in consequences such as unintentional overdoses, 
often owing to misperceptions that arise from the many mentioned compounds and combi‐
nations [32]. Countless people use alternative medicine for pain relief. There are indications 
that some medications relieve some kind of pain more efficiently than others [33]; however, 
additional research would be essential to improve comprehension of the uses of many alter‐
native medicine [34].
2.6. Plants as new sources of pain killers
Numerous medicinal plants and their derived phytochemicals were evaluated for their analge‐
sic and anti‐inflammatory effects. For example, extracts of bark as well as terpenoids obtained 
from Combretum molle (Combretaceae), β‐glucopyranosyl, and other isolated compounds have 
been documented to have an excellent potential against carrageenan‐induced paw edema 
in rats [7]. Similarly, Millettia versicolor crude extract and its isolated phytochemicals were 
found to inhibit 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA)‐induced acute ear edema and 
phospholipase A
2
 acute mouse paw edema [8]. Furthermore, chemical constituents isolated 
from various parts of Millettia griffoniana, Erythrina addisoniae, and Erythrina mildbraedii have 
been reported to exhibit significant anti‐inflammatory activity on induced‐paw edema and 
induced‐ear edema in mice [8], whereas compounds isolated from Erythrina sigmoidea have 
been shown to possess anti‐inflammatory activity against 12‐O‐tetradecanoylphorbol‐13‐ace‐
tate (TPA)‐induced ear edema [8]. Based on the above facts, the present chapter will focus on 
documenting the recent literature pertaining to medicinal plants and their phytochemicals 
and extracts as analgesics and in the treatment of inflammation.
2.7. Other natural products with analgesic properties
Natural products play a key role for living organisms. Primary metabolites are defined by Kossel 
as the main components of metabolic paths that are compulsory for life. Primary metabolites 
Pain Relief - From Analgesics to Alternative Therapies342
are related to important cellular roles, such as energy production, assimilation of nutrients, and 
development/growth. Secondary metabolites, in contrast to primary, are not essential and not 
required for the survival of living organisms [35–38].
Interestingly, secondary metabolites possess a broad range of functions. They comprise pher‐
omones, which can act as community gesturing molecules with additional individuals of the 
same species [39–41]. Communication molecules entice and stimulate a symbiotic organism 
and agents to solubilize and transport various nutrients, including siderophores, as well as 
good arms such as venoms, repellants, and toxins, which are used as a prey and predators 
competitors [42]. It has been documented in the literature that nearly 10 million organic com‐
pounds have been discovered and many new and novel compounds are still being isolated 
and characterized in various parts of the world.
Regarding these compounds, one hypothesis is that they present a good benefit to the living 
organism which makes them. Another view says that these compounds have similarity to the 
immune system of living organisms, and although they have no function, yet they can afford 
assorted bioactive compounds which have important biological activity [42].
Naturally obtained agents such as aspirin, morphine, codeine, thebaine, and others have been 
reported to have analgesic activity. Aspirin derived from salicylic acid extracted from barks 
of the willow tree (Salix alba) is one of the most extensively used compounds for the manage‐
ments of mild pain. On the other hand, morphine codeine and thebaine isolated from plants 
are used as analgesics (Figure 1) [43, 44].
Different types of active phytochemicals, such as steroids, alkaloids, tannins, phenol, and 
polyphenols are produced by medicinal plants [45–49]. In addition, a large number of plants 
that have been investigated are reported to have less pharmacologically active secondary 
metabolites identified. Plant‐derived molecules are mainly reported for their medical impor‐
tance; this includes morphine, nicotine, quinine, steroidal, and many others [50]. A large num‐
ber of presently recommended drugs have been derived from natural medicinal plants; some 
characteristic examples are given in next sections.
2.7.1. Salicin
It has been reported in the literature that extracted natural products possess analgesic activ‐
ity. The bark of willow trees has been recognized for pain‐relieving properties. It has been 
further reported that willow bark contains a bioactive compound, salicin, which hydrolyses 
into salicylic acid. As we know that derivative acetylsalicylic acid is known as aspirin and 
is used as a pain killer, the main mechanism of its action is inhibition of the cyclooxygenase 
enzyme (COX). There are two types of cyclooxygenase‐2 enzyme isozymes; COX‐1 (PTGS1) 
and COX‐2 (PTGS2). It is nonselective and permanently inhibits both form, but it is weakly 
more selective for COX‐1. COX produces prostaglandins most of them are pro‐inflammatory 
and thromboxanes, which promote clotting [51].
Nonsteroidal anti‐inflammatory drugs (NSAIDs) act via inhibition of cyclooxygenase enzyme 
(COX). Research findings suggest the opposing effects of nonsteroidal anti‐inflammatory 












































Figure 1. Chemical structures of analgesic compounds from medicinal plants.
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drugs on COX. These drugs act by blocking the COX‐1 enzyme, which catalyzes the pro‐
duction of prostaglandins that are involved in numerous physiological functions, such as (a) 
maintenance of normal renal function in the kidneys, (b) mucosal protection in the gastroin‐
testinal tract, and (c) proaggregatory thromboxane in the platelets. However, COX‐2 expres‐
sion can be induced by cytokines and other inflammatory mediators in a number of tissues, 
including endothelial cells, and is believed to have a role in the mediation of pain, inflamma‐
tion, and fever. COX‐2 agents only inhibit the COX‐2 enzyme, whereas traditional NSAIDs 
block both versions in general [16].
After extensive acceptance of the cyclooxygenase enzyme (COX‐2) inhibitors, it was revealed 
that many of the drugs in this class increase the risk of cardiovascular toxicity, which led to 
the removal of valdecoxib and rofecoxib, and others. On the other hand, etoricoxib appears 
comparatively safer to that of noncoxib NSAID diclofenac [17]. It is worth mentioning here 
that our research group has reported that pistagremic acid, a natural product isolated from 
Pistacia integerrima, can inhibit COX‐2 enzyme owing to the hydrogen and hydrophobic con‐
tacts to significant active sites of molecule [17].
The key uses of NSAID medication are typically for joint‐ and spine‐related pain. Its mech‐
anism of action is through interaction with pro‐inflammatory cytokines interleukin (IL‐1a, 
IL‐1b, IL‐6) and tumor necrosis factor (TNF‐α). Increased absorption of TNF‐α is thought to 
produce the cardinal symptoms of inflammation. These pro‐inflammatory cytokines result in 
chemo‐attractants for neutrophils and help them to stick to the endothelial from migration. 
They also stimulate white cell phagocytosis and the production of inflammatory lipid pros‐
taglandin E2 (PGE
2
). The ability of NSAIDs to interfere with the production of prostaglandin 
during inflammatory cascade is the major mechanism cited for success of pain of medication. 
In normal pain, the archidonic pathway proceeds and results in the production of highly 
reactive mediators that are prostaglandin, prostacycline, histamines, and many others. These 
mediators cause the start of pain in the body.
2.7.2. Morphine
An additional distinguished example is P. somniferum, a flowering poppy that yields opium, 
which contains a potent narcotic alkaloid constituent called morphine that acts as an opioid 
receptor [52]. Morphine binds to opioid receptors; molecular signaling activates the receptors 
to mediate certain actions. μ (Mu) receptors exist in the brain stem as well as in thalamus 
activation, these receptors result in relief of pain and sedation. Kappa receptor is found in the 
limbic system, part of forebrain, spinal cord, and brain stem. Activation these receptors result 
in relief of pain and sedation. Delta receptor found in brain, spinal cord, and digestive tract, 
stimulation of delta receptor leads to analgesic.
2.7.3. Ziconotide
Ziconotide, also known as SNX‐111, is a novel nonopioid analgesic drug. It is a synthetic 
version of ω‐conotoxin MVIIA (ω‐MVIIA), which is a peptide that is found in the venom of 
the fish‐eating marine snail, Conus magus. It is a powerful analgesic drug that acts through 
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a mechanism that involves selective block of N‐type calcium channels. This action inhibits 
the discharge of pronociceptive neurochemicals such as glutamate, calcitonin gene‐con‐
nected peptide, and material P in the brain and spinal cord, ensuing in pain relief. It has been 
approved for the treatment of severe chronic pain in patients only when administered by the 
intrathecal route. Importantly, prolonged administration of ziconotide does not lead to the 
development of addiction or tolerance [53].
2.7.4. Salvinorin
Salvinorin A is the main active psychotropic molecule in Salvia divinorum, a Mexican plant 
that has a long history of use as an entheogen by indigenous Mazatec shamans. Salvinorin A 
is considered a dissociative. It can produce psychoactive experiences in humans with a typi‐
cal duration of action being several minutes to an hour [54, 55]. Furthermore, Salvinorin is a 
trans‐neoclerodane diterpenoid, which acts as a κ‐opioid receptor agonist. The mechanism 
of action of Salvinorin A on ileal tissue has been described as prejunctional, as it was able to 
adjust electrically made contraction, but not those of exogenous acetylcholine. A pharmaco‐
logically important feature of the contraction‐reducing properties of ingested Salvinorin A on 
gut tissue is that it is only pharmacologically active on inflamed and not normal tissue, thus 
reducing possible side effects. Salvinorin produce a conditioned place aversion and decreases 
locomotors. It is able to modify dopaminergic pathway [55].
2.7.5. Pawhuskin A
Pawhuskin A is a bioactive naturally occurring stilbene reported from Dalea purpurea. 
Pawhuskin A has recognized to function as an opioid receptor antagonist, with special bind‐
ing to the k receptor. Pawhuskin A is the most active natural compound making a small group 
of nonnitrogenous compounds with effect on the opiate receptor system [56].
3. Conclusions
This chapter has focused on information and relevant literature pertaining to analgesic plants 
and their explored chemical constituents. Furthermore, unexplored medicinal plants reported 
to be used in folk medicine have been highlighted. This chapter also provides references to 
research carried out on analgesic drugs. Additionally, this chapter describes the main mecha‐
nisms of action of natural products poisoning presenting analgesic properties.
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